Clorox (CLX)
(Delayed Data from NYSE)
$161.57 USD
+0.20 (0.12%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $161.52 -0.05 (-0.03%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$161.57 USD
+0.20 (0.12%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $161.52 -0.05 (-0.03%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth B Momentum B VGM
Zacks News
Clorox Hits 52-Week High on Increased Demand for Disinfectant
by Zacks Equity Research
Clorox (CLX) gains from the increased demand for disinfectants after the coronavirus outbreak. Also, the company is witnessing strong progress in the core International business.
Clorox (CLX) Up 4.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Clorox (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
After a Brutal Week, Hopeful Investors Turn Their Eyes to the Fed
by David Borun
The possibility of central bank action promise to lift equities after the biggest declines in over a decade.
Stock Market News for Feb 5, 2020
by Zacks Equity Research
Wall Street closed sharply higher following news that the government of China is initiating several stimulus to protect its economy from coronavirus-led impacts
Clorox (CLX) Beats Q2 Earnings & Sales Estimates, Stock Up
by Zacks Equity Research
Clorox (CLX) second-quarter fiscal 2020 results reflect increase in gross margin. This marks the fifth straight quarter of gross margin growth.
Clorox (CLX) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Clorox (CLX) delivered earnings and revenue surprises of 11.45% and 1.39%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Things You Need to Know Before Clorox's (CLX) Q2 Earnings
by Sumit Singh
Clorox (CLX) has been witnessing operational headwinds in the Charcoal, and Bags and Wraps businesses, which have been hurting its Household segment, and in turn the top line for a while now.
Earnings Preview: Clorox (CLX) Q2 Earnings Expected to Decline
by Zacks Equity Research
Clorox (CLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Clorox (CLX) Down 9% in 3 Months: Can Efforts Aid Revival?
by Zacks Equity Research
Clorox (CLX) is grappling with softness in Charcoal, and Bags and Wraps businesses. Elevated costs remain a concern.
Soap & Cleaning Materials Stock Outlook Buoyant on Innovation
by Rajani Lohia
The FMCG space gains from continued investment in brands, innovation, cost-containment and pricing actions. Escalating operating costs and unfavorable currency rates are headwinds.
Clorox (CLX) Beats Q1 Earnings Estimates, Sales Miss (Revised)
by Zacks Equity Research
Clorox (CLX) reports earnings beat in first-quarter fiscal 2020. However, sales miss estimates on higher trade promotional spending, unfavorable mix, and adverse currency rates.
Clorox (CLX) Beats Earnings & Sales Estimates in Q1 (revised)
by Zacks Equity Research
Clorox (CLX) reports first-quarter fiscal 2020 results on higher trade promotional spending and unfavorable mix as well as adverse currency rates.
Clorox (CLX) Falls Short Of Earnings & Sales Estimates in Q1
by Zacks Equity Research
Clorox (CLX) reports dismal first-quarter fiscal 2020 results on higher trade promotional spending and unfavorable mix as well as adverse currency rates.
Clorox (CLX) Beats Q1 Earnings Estimates
by Zacks Equity Research
Clorox (CLX) delivered earnings and revenue surprises of 3.25% and -0.37%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Consumer Staples Earnings Slated for Oct 31: EL, CLX, CHD & AVP
by Rajani Lohia
Productivity efforts, improved pricing and marketing initiatives may have aided Consumer Staples companies in the to-be-reported quarter, while high costs and macro factors are likely to have hurt.
Analysts Estimate Clorox (CLX) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Clorox (CLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Factors Setting the Tone for Clorox's (CLX) Q1 Earnings
by Zacks Equity Research
Softness in Charcoal, and Bags and Wraps businesses is likely to have impacted Clorox (CLX) Q1 performance. High cost and unfavorable currency impacts are deterrents.
Clorox (CLX) Introduces IGNITE Strategy, Trims FY20 Guidance
by Zacks Equity Research
Clorox (CLX) introduces IGNITE strategy, which is built on a sturdy foundation of its 2020 Strategy. It aims to innovate in all areas of the business. However, management lowers view for fiscal 2020.
Clorox (CLX) Declines Post Soft FY20 View: Is This Temporary?
by Zacks Equity Research
Headwinds in the Charcoal, and Bags and Wraps businesses are hurting Clorox's (CLX) sales performance. But its robust fundamentals, initiatives and earnings trend indicate solid long-term prospects.
Clorox (CLX) Up 1.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Clorox (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Clorox (CLX) Q4 Earnings Top Estimates, Soft View Hurts Stock
by Zacks Equity Research
Clorox (CLX) reports mixed fourth-quarter fiscal 2019 results. Lower taxes and gross margin expansion aid its earnings while lower volume and unfavorable currency hurt sales.
Clorox (CLX) Q4 Earnings Top Estimates
by Zacks Equity Research
Clorox (CLX) delivered earnings and revenue surprises of 1.62% and -3.79%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Buy Procter & Gamble (PG) After Q4 Earnings Report?
by Christopher Vargas
Procter & Gamble (PG) reported its fiscal 2019 Q4 earnings before the opening bell on Tuesday.
Can Cost and Tariff Woes Mar Clorox's (CLX) Earnings in Q4?
by Zacks Equity Research
Clorox's (CLX) fourth-quarter fiscal 2019 results are likely to bear impacts of higher commodity costs, adverse currency, increased manufacturing and logistics expenses, and tariffs.
Clorox (CLX) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Clorox (CLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.